RU2018125702A - NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN - Google Patents

NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN Download PDF

Info

Publication number
RU2018125702A
RU2018125702A RU2018125702A RU2018125702A RU2018125702A RU 2018125702 A RU2018125702 A RU 2018125702A RU 2018125702 A RU2018125702 A RU 2018125702A RU 2018125702 A RU2018125702 A RU 2018125702A RU 2018125702 A RU2018125702 A RU 2018125702A
Authority
RU
Russia
Prior art keywords
amount
composition according
paragraphs
brain
infant
Prior art date
Application number
RU2018125702A
Other languages
Russian (ru)
Inventor
Нора ШНАЙДЕР
Шон ДЕОНИ
Тамаш БАРТФАИ
Йонас ХАУЗЕР
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Priority claimed from PCT/EP2016/080779 external-priority patent/WO2017102718A1/en
Publication of RU2018125702A publication Critical patent/RU2018125702A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)

Claims (24)

1. Питательная композиция для младенца и/или детей младшего возраста, содержащая производное жирной кислоты или смеси таких производных, для стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге. 1. A nutritional composition for an infant and / or young children, containing a fatty acid derivative or a mixture of such derivatives, to stimulate and / or maintain an optimal myelination trajectory in the brain. 2. Композиция по п. 1, причем оптимальная траектория миелинизации в головном мозге близка к траектории, наблюдаемой у младенцев, получавших исключительно человеческое грудное молоко в течение первых месяцев жизни.2. The composition according to claim 1, wherein the optimal path of myelination in the brain is close to the path observed in infants who received exclusively human breast milk during the first months of life. 3. Композиция по любому из пп. 1 или 2, причем она стимулирует и/или поддерживает состояние здоровья, характеризующееся оптимальным развитием головного мозга и когнитивных функций и/или профилактикой нейрокогнитивных расстройств. 3. The composition according to any one of paragraphs. 1 or 2, and it stimulates and / or maintains a state of health characterized by optimal development of the brain and cognitive functions and / or prevention of neurocognitive disorders. 4. Композиция по любому из пп. 1-3, которая содержит DHA и/или ARA в количестве более 30 мг/100 г.4. The composition according to any one of paragraphs. 1-3, which contains DHA and / or ARA in an amount of more than 30 mg / 100 g. 5. Композиция по любому из пп. 1-4, которая также содержит железо.5. The composition according to any one of paragraphs. 1-4, which also contains iron. 6. Композиция по любому из пп. 1-5, которая также содержит сфингомиелин.6. The composition according to any one of paragraphs. 1-5, which also contains sphingomyelin. 7. Композиция по любому из пп. 1-6, которая также содержит фолиевую кислоту.7. The composition according to any one of paragraphs. 1-6, which also contains folic acid. 8. Композиция по любому из пп. 1-7, которая также содержит холин.8. The composition according to any one of paragraphs. 1-7, which also contains choline. 9. Применение композиции по любому из пп. 1-8 для стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге у младенца или детей младшего возраста.9. The use of the composition according to any one of paragraphs. 1-8 to stimulate and / or maintain an optimal trajectory of myelination in the brain in an infant or young children. 10. Применение композиции по любому из пп. 1-8 для профилактики субоптимальной траектории миелинизации в головном мозге у младенца или детей младшего возраста.10. The use of the composition according to any one of paragraphs. 1-8 for the prevention of a suboptimal trajectory of myelination in the brain in an infant or young children. 11. Способ стимуляции и/или поддержания оптимальной траектории миелинизации в головном мозге у младенца и/или детей младшего возраста, включающий введение такому младенцу и/или детям младшего возраста питательной композиции, содержащей производное жирной кислоты или смеси таких производных, в частности ARA и/или DHA.11. A method of stimulating and / or maintaining an optimal path of myelination in the brain in an infant and / or young children, comprising administering to such an infant and / or young children a nutritional composition containing a fatty acid derivative or a mixture of such derivatives, in particular ARA and / or DHA. 12. Способ по п. 11, в котором композицию по любому из пп. 1-8 вводят младенцу и/или детям младшего возраста.12. The method according to p. 11, in which the composition according to any one of paragraphs. 1-8 is administered to an infant and / or young children. 13. Питательная композиция, содержащая:13. A nutritional composition comprising: сфингомиелин в количестве более 200 мг/кг;sphingomyelin in an amount of more than 200 mg / kg; железо в количестве более 5 мг/100 г;iron in an amount of more than 5 mg / 100 g; холин в количестве более 30 мг/100 г;choline in an amount of more than 30 mg / 100 g; ARA и/или DHA в количестве более 30 мг/100 г;ARA and / or DHA in an amount of more than 30 mg / 100 g; фолиевую кислоту в количестве более 50 мкг/100 г.folic acid in an amount of more than 50 mcg / 100 g. 14. Питательная композиция, содержащая:14. A nutritional composition comprising: сфингомиелин в количестве в диапазоне от 200 мг до 2 г/кг;sphingomyelin in an amount in the range from 200 mg to 2 g / kg; железо в количестве в диапазоне от 5 до 40 мг/100 г;iron in an amount in the range from 5 to 40 mg / 100 g; холин в количестве в диапазоне от 30 до 1000 мг/100 г;choline in an amount in the range from 30 to 1000 mg / 100 g; ARA и/или DHA в количестве в диапазоне от 30 до 300 мг/100 г;ARA and / or DHA in an amount ranging from 30 to 300 mg / 100 g; фолиевую кислоту в количестве в диапазоне от 50 до 500 мкг/100 г.folic acid in an amount in the range of 50 to 500 mcg / 100 g.
RU2018125702A 2015-12-14 2016-12-13 NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN RU2018125702A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP15199769.9 2015-12-14
EP15199769 2015-12-14
US201662315187P 2016-03-30 2016-03-30
US201662315280P 2016-03-30 2016-03-30
US62/315,280 2016-03-30
US62/315,187 2016-03-30
US201662328047P 2016-04-27 2016-04-27
US62/328,047 2016-04-27
PCT/EP2016/080779 WO2017102718A1 (en) 2015-12-14 2016-12-13 Nutritional compositions and infant formulas to promote myelination in the brain

Publications (1)

Publication Number Publication Date
RU2018125702A true RU2018125702A (en) 2020-01-16

Family

ID=65529010

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018125702A RU2018125702A (en) 2015-12-14 2016-12-13 NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN

Country Status (2)

Country Link
CL (1) CL2018001597A1 (en)
RU (1) RU2018125702A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
PT3389407T (en) 2015-12-14 2024-01-19 Nestle Sa Nutritional composition and infant formula for promoting de novo myelination

Also Published As

Publication number Publication date
CL2018001597A1 (en) 2018-10-05

Similar Documents

Publication Publication Date Title
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
RU2011150191A (en) LACTOFERRIN AND NEURAL HEALTH AND INTESTINAL DEVELOPMENT IN INFANTS
KR20020025088A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
RU2014123509A (en) MIXTURE FOR BABY FOOD WITH A HIGH CONTENT OF SN-2-PALMITATE AND OLIGOFRUKTOSA
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
PH12020550341A1 (en) Niraparib formulations
RU2015122497A (en) LACTOFERRINE-CONTAINING NUTRITIONAL COMPOSITIONS ON THE BASIS OF MILK AND THEIR APPLICATION
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
BR112015022995A2 (en) infant nutritional product with rrr-alpha tocopherol
RU2011150189A (en) PREVENTION AND TREATMENT OF ALLERGIC DIARRHEA
PH12016500763A1 (en) Synthetic milk compositions comprising polyunsaturated fatty acids (pufas) for promoting the healthy establishment of cognitive function in male and female infant and children
RU2018125702A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN
RU2018125503A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES TO STIMULATE MYELINATION IN THE BRAIN
PH12016500772A1 (en) Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function
PH12018500988A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2012015123A (en) Early programming of brain function through soy protein feeding.
RU2018125497A (en) NUTRITIONAL COMPOSITIONS AND BABY MIXTURES FOR ACTIVATING MYELINATION IN THE BRAIN
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
RU2019141949A (en) NUTRIENT COMPOSITION FOR USE IN INCREASING ATTENTION AND / OR REDUCING IMPULSE
RU2014132846A (en) GLUTAMINE-ENRICHED NUTRITION FOR INFANTS
CN105341919B (en) A kind of pharmaceutical composition for improving memory and preparation method thereof
TWI774433B (en) Lithium salts of n-substituted glycine compounds and uses thereof
RU2013154564A (en) METHODS AND COMPOSITIONS FOR STIMULATING GROWTH OF AN OIL-FREE BODY WEIGHT
RU2016112528A (en) LACTOFERRIN, IMPROVEMENT OF MEMORY AND IMPROVEMENT OF SPEED OF LEARNING IN CHILDREN
PH12018501150A1 (en) Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20191216